- Home
- UAN vs QURE Comparison
UAN vs QURE Comparison
Compare UAN & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UAN | QURE |
|---|---|---|
| Founded | 2007 | 1998 |
| Country | United States | Netherlands |
| Employees | N/A | 248 |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2008 | 2013 |
Fundamental Metrics
Financial Performance| Metric | UAN | QURE |
|---|---|---|
| Price | $127.50 | $43.22 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $45.00 |
| AVG Volume (30 Days) | 18.8K | ★ 1.5M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 7.91% | N/A |
| EPS Growth | ★ 61.98 | 29.67 |
| EPS | ★ 12.06 | N/A |
| Revenue | ★ $606,038,000.00 | $13,107,000.00 |
| Revenue This Year | N/A | $126.12 |
| Revenue Next Year | N/A | $200.43 |
| P/E Ratio | $10.60 | ★ N/A |
| Revenue Growth | ★ 15.36 | N/A |
| 52 Week Low | $86.43 | $8.73 |
| 52 Week High | $139.50 | $71.50 |
Technical Indicators
Market Signals| Indicator | UAN | QURE |
|---|---|---|
| Relative Strength Index (RSI) | 66.91 | 61.65 |
| Support Level | $121.55 | $21.16 |
| Resistance Level | $139.42 | $50.47 |
| Average True Range (ATR) | 2.80 | 2.16 |
| MACD | 0.91 | -0.16 |
| Stochastic Oscillator | 83.90 | 92.33 |
Price Performance
Historical ComparisonAbout UAN CVR Partners LP
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.